Literature DB >> 28242196

MicroRNA-520e suppresses non-small-cell lung cancer cell growth by targeting Zbtb7a-mediated Wnt signaling pathway.

Zhu Zhijun1, He Jingkang2.   

Abstract

MicroRNAs (miRNAs) that negatively regulated gene expression have emerged as novel therapeutic target for non-small-cell lung cancer (NSCLC) treatment. In this study, we investigated the potential role of miR-520e and examined its functional role in NSCLCs. Loss-and-gain of function assays show that miR-520e significantly modulated NSCLC cell growth, cell invasion and cell migration via directly targeting the 3'-untranslated region (UTR) of Zbtb7a and therefore reduced Zbtb7a protein level. These effects of miR-520e on NSCLC progression could be rescued by Zbtb7a overexpression in A549 cells. Furthermore, both of miR-520e level and Zbtb7a level were correlated with Wnt signaling in NSCLC cells. Taken together, these results indicate that overexpressing miR-520e is involved in regulating the NSCLC cell growth, invasion and migration by targeting Zbtb7a partly depending on Wnt signaling.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MicroRNAs; Non-small-cell lung cancer; Wnt signaling; Zbtb7a; miR-520e

Mesh:

Substances:

Year:  2017        PMID: 28242196     DOI: 10.1016/j.bbrc.2017.02.121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Circular RNA Circ_0016760 Modulates Non-Small-Cell Lung Cancer Growth Through the miR-577/ZBTB7A Axis.

Authors:  Yanhong Hao; Junfeng Xi; Yancai Peng; Burong Bian; Guangjun Hao; Yunfeng Xi; Zhibin Zhang
Journal:  Cancer Manag Res       Date:  2020-07-08       Impact factor: 3.989

2.  Long Non-Coding RNA SNHG14 Impedes Viability, Migration and Invasion of Endometrial Carcinoma Cells Through Modulating miR-93-5p/ZBTB7A Axis.

Authors:  Kai Zhang; Yongqin Cai; Qi Zhou; Hong Sun; Jinying Wei
Journal:  Cancer Manag Res       Date:  2020-10-01       Impact factor: 3.989

3.  MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.

Authors:  Junlei Han; Jianping Hu; Fang Sun; Hongzhi Bian; Bingxiang Tang; Xiang Fang
Journal:  Mol Cell Biochem       Date:  2020-10-30       Impact factor: 3.396

4.  Circulating microRNA-34 family low expression correlates with poor prognosis in patients with non-small cell lung cancer.

Authors:  Ke Zhao; Jing Cheng; Baojun Chen; Qi Liu; Di Xu; Yongjian Zhang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 5.  Role of ZBTB7A zinc finger in tumorigenesis and metastasis.

Authors:  Atul Kumar Singh; Shiv Verma; Prem Prakash Kushwaha; Kumari Sunita Prajapati; Mohd Shuaib; Shashank Kumar; Sanjay Gupta
Journal:  Mol Biol Rep       Date:  2021-05-20       Impact factor: 2.316

6.  CyclinD1 Is a New Target Gene of Tumor Suppressor MiR-520e in Breast Cancer.

Authors:  Quan Liang; Qingjuan Yao; GuoYing Hu
Journal:  Open Med (Wars)       Date:  2019-12-04

7.  ZBTB7A functioned as an oncogene in colorectal cancer.

Authors:  Li Wang; Meng-Xia Zhang; Mei-Fang Zhang; Zi-Wei Tu
Journal:  BMC Gastroenterol       Date:  2020-11-09       Impact factor: 3.067

8.  Long non-coding RNA p53 upregulated regulator of p53 levels (PURPL) promotes the development of gastric cancer.

Authors:  Zhonghua Cheng; Jing Hong; Nan Tang; Fenghua Liu; Shuo Gu; Zhen Feng
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 9.  The multi-faceted functioning portrait of LRF/ZBTB7A.

Authors:  Caterina Constantinou; Magda Spella; Vasiliki Chondrou; George P Patrinos; Adamantia Papachatzopoulou; Argyro Sgourou
Journal:  Hum Genomics       Date:  2019-12-10       Impact factor: 4.639

10.  Krüppel-like factor 1 (KLF1) promoted the proliferation, migration and invasion of human lens epithelial cells by enhancing the expression of Zinc Finger and BTB Domain Containing 7A (ZBTB7A) and activating Wnt/β-catenin pathway.

Authors:  Guangming Shi; Feng Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.